Papers authored by Cleveland SM

Collect these papers and discover other ones on Labmeeting. Learn more.
Murine Leukemias with Retroviral Insertions at Lmo2 Are Predictive of the Leukemias Induced in SCID-X1 Patients Following Retroviral Gene Therapy.
+ cite this
+ View Abstract
Davé UP, Akagi K, Tripathi R, Cleveland SM, Thompson MA, Yi M, Stephens R, Downing JR, Jenkins NA, and Copeland NG
PLoS genetics 5(5):e1000491, 2009 May - Who cited this? | PubMed ID: 19440365 | Fulltext
Recommend
Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias induced in SCID-X1 patients following retroviral gene therapy.
+ cite this
+ View Abstract
Davé UP, Akagi K, Tripathi R, Cleveland SM, Thompson MA, Yi M, Stephens R, Downing JR, Jenkins NA, and Copeland NG
PLoS genetics 5(5):e1000491, 2009 May - Who cited this? | PubMed ID: 19461887 | Fulltext
Recommend
Assessment of a bovine viral diarrhea virus antigen capture ELISA and a microtiter virus isolation ELISA using pooled ear notch and serum samples.
+ cite this
+ View Abstract
Cleveland SM, Salman MD, and Van Campen H
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 18(4):395-8, 2006 Jul - Who cited this? | PubMed ID: 16921882 | Fulltext
Recommend
A region of the C-terminal tail of the gp41 envelope glycoprotein of human immunodeficiency virus type 1 contains a neutralizing epitope: evidence for its exposure on the surface of the virion.
+ cite this
+ View Abstract
Cleveland SM, McLain L, Cheung L, Jones TD, Hollier M, and Dimmock NJ
The Journal of general virology 84(Pt 3):591-602, 2003 Mar - Who cited this? | PubMed ID: 12604810 | Fulltext
Recommend
Different effects of a single amino acid substitution on three adjacent epitopes in the gp41 C-terminal tail of a neutralizing antibody escape mutant of human immunodeficiency virus type 1.
+ cite this
+ View Abstract
McLain L, Brown JL, Cheung L, Reading SA, Parry C, Jones TD, Cleveland SM, and Dimmock NJ
Archives of virology 146(1):157-66, 2001 - Who cited this? | PubMed ID: 11266210 | Fulltext
Recommend
Properties of a neutralizing antibody that recognizes a conformational form of epitope ERDRD in the gp41 C-terminal tail of human immunodeficiency virus type 1.
+ cite this
+ View Abstract
Cleveland SM, Jones TD, and Dimmock NJ
The Journal of general virology 81(Pt 5):1251-60, 2000 May - Who cited this? | PubMed ID: 10769067 | Fulltext
Recommend
Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
+ cite this
+ View Abstract
Cleveland SM, Buratti E, Jones TD, North P, Baralle F, McLain L, McInerney T, Durrani Z, and Dimmock NJ
Virology 266(1):66-78, 2000 Jan 5 - Who cited this? | PubMed ID: 10612661 | Fulltext
Recommend
The neutralizing antibody response against a conserved region of human immunodeficiency virus type 1 gp41 (amino acid residues 731-752) is uniquely directed against a conformational epitope.
+ cite this
+ View Abstract
Buratti E, McLain L, Tisminetzky S, Cleveland SM, Dimmock NJ, and Baralle FE
The Journal of general virology 79 ( Pt 11):2709-16, 1998 Nov - Who cited this? | PubMed ID: 9820146 | Fulltext
Recommend
Selection of neutralizing antibody escape mutants with type A influenza virus HA-specific polyclonal antisera: possible significance for antigenic drift.
+ cite this
+ View Abstract
Cleveland SM, Taylor HP, and Dimmock NJ
Epidemiology and infection 118(2):149-54, 1997 Apr - Who cited this? | PubMed ID: 9129591 | Fulltext
Recommend



Search Google Scholar for Cleveland SM

Join Labmeeting

  • Organize and search your PDF collection
  • Collect papers
  • Search millions of papers
  • Keep up to date with paper alerts
  • Read your papers from anywhere
  • Recommend papers to colleagues
  • Manage your lab
Sign Up

Join Labmeeting

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.


Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!